SpA Screening IDs 'High Burden of Need' in Patients With IBD
More than 40% of patients with IBD screened positive for joint pain in a multicenter study, yet few patients had seen a rheumatologist in the past year.
Source: medscape.com
Page 11 - Icahn School News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Icahn School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Icahn School Today - Breaking & Trending Today
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia.
Source: medscape.com
Arrowhead Pharmaceuticals, Inc.: Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
Zodasiran significantly reduced triglycerides and atherogenic triglyceride rich lipoproteins across all dose levels at Week 24 Data presented at European Atherosclerosis Society 92nd Congress and
Source: finanznachrichten.de
Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
29.05.2024 - Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 2b double blind, randomized ARCHES-2 study of investigational zodasiran (formerly ARO-ANG3) in patients with mixed hyperlipidemia. Zodasiran was associated with ... Seite 1
Source: wallstreet-online.de
RNA Inhibitor Is Shown Safe and Effective in Reduc
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by M
Source: newswise.com